# Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain

> **NCT01875848** · PHASE4 · TERMINATED · sponsor: **VA Office of Research and Development** · enrollment: 7 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** buprenorphine/naloxone
- **DRUG:** opioid dose escalation

## Key facts

- **NCT ID:** NCT01875848
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-12
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Data safety monitoring board recommended due to low recruitment yield.
- **Last updated:** 2016-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01875848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01875848, "Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01875848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*